找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Amlodipine; Winifred G. Nayler Book 1993 Springer-Verlag Berlin Heidelberg 1993 Ca++-channel.Calcium-antagonist.PTCA.cardiovascular.hypert

[復(fù)制鏈接]
樓主: 極大
11#
發(fā)表于 2025-3-23 11:07:35 | 只看該作者
,Calcium Antagonists and the Stunned Heart — Are Vascular Selective Antagonists Protective?,onary blood flow is severe and sustained, then the inevitable outcome is that the cells in the affected area are doomed to die and necrose, irrespective of whether the tissue is subsequently reperfused (Jennings et al., 1990). Not all episodes of ischaemia are sustained and severe, however. For exam
12#
發(fā)表于 2025-3-23 16:44:42 | 只看該作者
13#
發(fā)表于 2025-3-23 21:35:31 | 只看該作者
14#
發(fā)表于 2025-3-24 00:47:10 | 只看該作者
15#
發(fā)表于 2025-3-24 04:01:22 | 只看該作者
16#
發(fā)表于 2025-3-24 09:05:00 | 只看該作者
Calcium Antagonists and Heart Failure,idity and mortality. In America, for example, one percent of the population already suffers from the complaint, and there are approximately four hundred thousand new cases presenting for treatment each year. (Sonnenblick et al., 1991). Even more disturbing is the prediction that as therapy for the m
17#
發(fā)表于 2025-3-24 13:52:27 | 只看該作者
The Side-Effects of Calcium Antagonist Therapy. Is Amlodipine Different?,ol would undoubtedly lack any appreciable side-effects. Unfortunately, and despite its obvious attraction, even the concept or a Utopian world is pure fantasy, as is the likelihood of effective therapeutic agents being developed which lack any side-effects. In reality physicians have had to cope wit
18#
發(fā)表于 2025-3-24 16:48:22 | 只看該作者
19#
發(fā)表于 2025-3-24 20:22:54 | 只看該作者
Erratum to: Die Stochastik der Iterationen, writing “Man and Superman”, because whilst it is a truism to say that . few investigators could have anticipated the recent developments which have taken place in the field of calcium antagonism. Not only was much of this progress unanticipated; at first sight it may even seem to be unreasonable. F
20#
發(fā)表于 2025-3-25 00:34:58 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-24 07:47
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
额济纳旗| 汾西县| 崇仁县| 乃东县| 方正县| 甘孜县| 江西省| 恭城| 商洛市| 高要市| 刚察县| 临朐县| 隆德县| 永春县| 华阴市| 绍兴市| 东平县| 阿图什市| 宜阳县| 绥滨县| 福建省| 武穴市| 若羌县| 鸡西市| 太原市| 安丘市| 湖口县| 苏州市| 灵川县| 平塘县| 泸水县| 宕昌县| 贵阳市| 通道| 华亭县| 洛隆县| 布尔津县| 金塔县| 五莲县| 屏东县| 白银市|